ONCOLife Articles
DNA-Based Immunotherapy IMNN-001 Shows Survival Gains in Advanced Ovarian Cancer
Clinical Trials | 23 May 2025
How the Integration of START and CURC Is Advancing Cancer Research and Clinical Trials
ONCOLife | 22 May 2025
START Doses First Patient in Trial of mRNA-4106, a Pan-Tumor Therapy for Solid Tumors
Clinical Trials | 15 May 2025
FDA Approves Emrelis as the First Targeted ADC for High c-Met Expressing Lung Cancer
FDA & EMA | 15 May 2025
V Foundation and Cancer Vaccine Coalition Partner to Accelerate Breast Cancer Vaccine
ONCOLife | 14 May 2025
Bria-IMT’s Early Promise: Biomarkers Signal Path to Personalized Therapy in Breast Cancer
Clinical Trials
2 May 2025
Leucid Bio Doses First Patient in Trial of LEU011, a CAR-T Therapy for Solid Tumors
Clinical Trials
12 May 2025
Zongertinib Demonstrates 71% Response Rate in HER2-Mutant Lung Cancer Treatment
Clinical Trials
2 May 2025
Elraglusib Shows Survival Benefit in First-Line Metastatic Pancreatic Cancer Trial
Clinical Trials
7 May 2025
First-Ever KRAS G12D Inhibitor Zoldonrasib Shows 61% Response Rate in Lung Cancer
Clinical Trials
30 April 2025
Oncologists Struggle with Innovation Overload: 'The Growing Chasm in Cancer Care'
ONCOLife
10 May 2025
New AI-Powered Urine Test Detects Prostate Cancer with Higher Precision than PSA
ONCOLife
2 May 2025
Pembrolizumab Improves Event-Free Survival in Resectable Head and Neck Cancer
Clinical Trials
28 April 2025
Bayer Launches First-in-Human Trial of Targeted Alpha Therapy for Advanced Liver Cancer
Clinical Trials
30 April 2025
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
